181 related articles for article (PubMed ID: 34768205)
1. Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase.
Yapar G; Esra Duran H; Lolak N; Akocak S; Türkeş C; Durgun M; Işık M; Beydemir Ş
Bioorg Chem; 2021 Dec; 117():105473. PubMed ID: 34768205
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.
Demir Y; Tokalı FS; Kalay E; Türkeş C; Tokalı P; Aslan ON; Şendil K; Beydemir Ş
Mol Divers; 2023 Aug; 27(4):1713-1733. PubMed ID: 36103032
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3H)-one derivatives as potential aldose reductase inhibitors.
Tokalı FS; Demir Y; Demircioğlu İH; Türkeş C; Kalay E; Şendil K; Beydemir Ş
Drug Dev Res; 2022 May; 83(3):586-604. PubMed ID: 34585414
[TBL] [Abstract][Full Text] [Related]
5. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
Celestina SK; Sundaram K; Ravi S
Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
[TBL] [Abstract][Full Text] [Related]
7. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
[TBL] [Abstract][Full Text] [Related]
8. Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket.
Hlaváč M; Kováčiková L; Šoltésová Prnová M; Addová G; Hanquet G; Štefek M; Boháč A
Bioorg Med Chem; 2021 Jan; 29():115885. PubMed ID: 33271452
[TBL] [Abstract][Full Text] [Related]
9. A new series of hydrazones as small-molecule aldose reductase inhibitors.
Altıntop MD; Demir Y; Türkeş C; Öztürk RB; Cantürk Z; Beydemir Ş; Özdemir A
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200570. PubMed ID: 36603162
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling, selective aldose reductase inhibition and hypoglycemic activity of novel meglitinides.
Salem MG; Abdel Aziz YM; Elewa M; Nafie MS; Elshihawy HA; Said MM
Bioorg Chem; 2021 Jun; 111():104909. PubMed ID: 33895603
[TBL] [Abstract][Full Text] [Related]
11. Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications.
Vyas B; Choudhary S; Singh PK; Kumar M; Verma H; Singh M; Malik AK; Silakari O
Bioorg Chem; 2020 Mar; 96():103570. PubMed ID: 31978681
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
13. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
[TBL] [Abstract][Full Text] [Related]
14. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
[TBL] [Abstract][Full Text] [Related]
15. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
[TBL] [Abstract][Full Text] [Related]
16. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
[TBL] [Abstract][Full Text] [Related]
17. Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition.
Shehzad MT; Hameed A; Al-Rashida M; Imran A; Uroos M; Asari A; Mohamad H; Islam M; Iftikhar S; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Nov; 92():103244. PubMed ID: 31541804
[TBL] [Abstract][Full Text] [Related]
18. (5-Hydroxy-4-oxo-2-styryl-4
Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
[TBL] [Abstract][Full Text] [Related]
19. Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.
Kumar M; Choudhary S; Singh PK; Silakari O
Future Med Chem; 2020 Jul; 12(14):1327-1358. PubMed ID: 32602375
[TBL] [Abstract][Full Text] [Related]
20. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
Huang W; Zhang Y; Liang X; Yang L
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]